학술논문
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study
Document Type
Article
Author
Source
In: Breast . (Breast, April 2024, 74)
Subject
Language
English
ISSN
15323080
09609776
09609776